Here is your Forbes Daily Briefing for Friday, July 11th.

Today on Forbes, this startup built a hospital in India to test its AI software.

As longtime cancer doctors with regulatory experience, Pi Health co-founders Jeff Kim and Bobby Reddy

knew that completing clinical trials took far too long.

There was the painfully slow process of signing up patients, and after that, a grueling slog

through vast swamps of data to prepare voluminous regulatory filings, something that few

hospitals and clinics can handle.

The pair knew their startup's best chance of success meant doing an end run around

all that. So they did something audacious and unprecedented. They built their own cancer

hospital in India. Clinical trials are an enormous bottleneck in drug development, and Kim and Reddy

thought the AI-enabled software they'd been building at Pi Health could help do them

faster and cheaper by expanding the pool of potentially eligible patients.

But the majority of clinical trials today are done in top-notch academic medical centers,

and first they needed to prove that their AI-enabled software could help overseas hospitals

and smaller community cancer centers

handle the documentation required to get through regulatory approval.

So they found a site in Hyderabad, a major technology and pharmaceutical center in southern

India, and built a 30-bed, state-of-the-art cancer hospital.

Pye Health Cancer Hospital opened in September 2023 and began running clinical trials last year.

It's participated in eight so far, including one that helped lead to a drug for head, neck,

and lung cancer being approved in India just seven months after the first Indian patient was

enrolled in the study.

...